Clinical trial · Observational
System to Evaluate the Risk of Lymph Node Metastasis Preoperatively in Cervical Cancer
Preoperative Scoring System to Predict the Risk of Lymph Node Metastasis in Cervical Cancer
NCT06032481CI-TRIAL-00069566completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The lymph node status is difficult to be assessed preoperatively, this study aimed to develop a scoring system for predicting the risk of LNM in cervical cancer patients before operation.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cervical Cancer | Malignant Cervical Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| surgery | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Overall survival
- timeFrame
- 60 months
- description
- death or loss of follow-up
Secondary outcomes (2)
- measure
- Risk factors influenced LNM
- timeFrame
- 60 months
- description
- A multivariable logistic regression analysis was used to analysis the independent factors that contribute to LNM.
- measure
- The accuracy of the model
- timeFrame
- 60 months
- description
- The AUC curve was used to assess the discrimination of the scoring system. The comparison between predicted (mean ± SD) and observed rates of LNM was used to test the calibration. The Hosmer-Lemeshow test evaluated the model fit.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 25 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * Clinical diagnosis of cervical cancer * FIGO stage IB1-IIA1 * Undergone radical hysterectomy with pelvic lymphadenectomy * Peformed pelvic MRI examination preoperatively Exclusion Criteria: * Had distant metastases diagnosed before or during the surgery * Underwent neoadjuvant radiotherapy preoperatively * Underwent neoadjuvant chemotherapy preoperatively * Incomplete or inaccuratemedical records
References
Publications (0)
Data not yet available
No reference posted for this study.